Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Search content at Luxembourg Institute of Health
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Experimental vaccines against measles in a world of changing epidemiology
Mike M. Pütz
, Fabienne B. Bouche
, Rik L. De Swart
,
Claude P. Muller
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Review article
›
peer-review
35
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Experimental vaccines against measles in a world of changing epidemiology'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Aerosol
33%
Bacterial Vectors
33%
Changing Epidemiology
100%
Clinical Trials
33%
Complex Peptides
33%
Eradication Therapy
33%
Experimental Vaccines
100%
Immaturity
33%
Immune Stimulating Complexes
33%
Immunogenic
33%
Infant Immune System
33%
Live Attenuated
66%
Live Vaccine
33%
Maternal Antibodies
33%
Measles
100%
Measles Elimination
33%
Measles Eradication
33%
Measles Virus
100%
Medical Intervention
33%
Monkey
33%
Naked DNA
33%
Natural Immunity
33%
Natural Protection
33%
Neutralizing Epitope
33%
Organizational Goals
33%
Potential Threats
33%
Recombinant Viral Protein
33%
Synthetic Peptides
33%
Vaccination
33%
Vaccine Candidate
66%
Vaccine Virus
33%
Viral Vectors
33%
Virus Spread
33%
World Health Organization
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bacterial Vector
33%
Clinical Trial
33%
Elimination
33%
Epidemiology
100%
Epitope
33%
Immaturity
33%
ISCOM
33%
Live Vaccine
33%
Maternal Antibody
33%
Measles
100%
Measles Vaccine
100%
Naked DNA
33%
Synthetic Peptide
33%
Vaccination
33%
Viral Protein
33%
Viral Vector
33%
Virus Vaccine
33%